Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
Saved in:
| Title: | Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy. |
|---|---|
| Authors: | Seung Tae Kim1, Jeeyun Lee1, Se Hoon Park1, Joon Oh Park1, Young Suk Park1, Won Ki Kang1, Ho Yeong Lim1 hoy.lim@samsung.com, Kim, Seung Tae2 (AUTHOR), Lee, Jeeyun2 (AUTHOR), Park, Se Hoon2 (AUTHOR), Park, Joon Oh2 (AUTHOR), Park, Young Suk2 (AUTHOR), Kang, Won Ki2 (AUTHOR), Lim, Ho Yeong2 (AUTHOR) |
| Source: | BMC Cancer. 3/23/2017, Vol. 17, p1-6. 6p. 3 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 122046046 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Seung+Tae+Kim%22">Seung Tae Kim</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Jeeyun+Lee%22">Jeeyun Lee</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Se+Hoon+Park%22">Se Hoon Park</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Joon+Oh+Park%22">Joon Oh Park</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Young+Suk+Park%22">Young Suk Park</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Won+Ki+Kang%22">Won Ki Kang</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ho+Yeong+Lim%22">Ho Yeong Lim</searchLink><relatesTo>1</relatesTo><i> hoy.lim@samsung.com</i><br /><searchLink fieldCode="AR" term="%22Kim%2C+Seung+Tae%22">Kim, Seung Tae</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+Jeeyun%22">Lee, Jeeyun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park%2C+Se+Hoon%22">Park, Se Hoon</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park%2C+Joon+Oh%22">Park, Joon Oh</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park%2C+Young+Suk%22">Park, Young Suk</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kang%2C+Won+Ki%22">Kang, Won Ki</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim%2C+Ho+Yeong%22">Lim, Ho Yeong</searchLink><relatesTo>2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 3/23/2017, Vol. 17, p1-6. 6p. 3 Charts, 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=122046046 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-017-3196-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 1 Titles: – TitleFull: Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Seung Tae Kim – PersonEntity: Name: NameFull: Jeeyun Lee – PersonEntity: Name: NameFull: Se Hoon Park – PersonEntity: Name: NameFull: Joon Oh Park – PersonEntity: Name: NameFull: Young Suk Park – PersonEntity: Name: NameFull: Won Ki Kang – PersonEntity: Name: NameFull: Ho Yeong Lim – PersonEntity: Name: NameFull: Kim, Seung Tae – PersonEntity: Name: NameFull: Lee, Jeeyun – PersonEntity: Name: NameFull: Park, Se Hoon – PersonEntity: Name: NameFull: Park, Joon Oh – PersonEntity: Name: NameFull: Park, Young Suk – PersonEntity: Name: NameFull: Kang, Won Ki – PersonEntity: Name: NameFull: Lim, Ho Yeong IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 03 Text: 3/23/2017 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 17 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |